Keros Therapeutics, Inc. (KROS)
20.26
+0.13
(+0.65%)
USD |
NASDAQ |
Dec 19, 16:00
20.21
-0.05
(-0.25%)
After-Hours: 20:00
Keros Therapeutics Market Cap: 617.24M for Dec. 19, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 958.96B |
| Pfizer Inc. | 143.22B |
| Innoviva, Inc. | 1.495B |
| Ocugen, Inc. | 437.25M |
| Bionano Genomics, Inc. | 16.18M |
Market Cap Related Metrics
| PE Ratio | 13.13 |
| PS Ratio | 3.338 |
| Price to Book Value | 0.8773 |
| Price to Free Cash Flow | 9.457 |
| Price | 20.26 |
| Earnings Yield | 7.62% |
| Operating PE Ratio | 18.90 |
| Normalized PE Ratio | 13.13 |